Acobiom is specialized in the discovery of new Biomarkers and in the development of innovative Diagnostics focused on Translational Research, Personalized Medicine and Precision Medicine.

The company provides also customized Omics services in genomics, transcriptomics, bioinformatics and biostatistics, thanks to its technology platform and its scientific expertise.


Biomarkers and Diagnostics for Personalized Medicine, Precision Medicine, and Translational Research

The objective is to associate drugs or treatments with Biomarkers or (companion) Diagnostics to determine the sub-population of patients the most likely to benefit from these therapies.

Customized Omics services for Translational Research and Clinical Development

Based on its over 18 years experience and its technology platform, Acobiom provides a wide range of Omics services. The objective: making sense to biological data.

Bioinformatics and biostatistics bringing more value to Omics (Big) Data

Acobiom provides state-of-art bioinformatics and biostatistics analyses able to analyze Omics (Big) Data obtained through Next-Generation Sequencing (NGS) and qPCR